Related Videos

Ada Waks, MD Presents Results of the MARGOT Study Video

Ada Waks, MD Presents Results of the MARGOT Study

Dana-Farber's Ada Waks, MD presented results of MARGOT, a phase 2 trial comparing margetuximab plus chemo or trastuzumab plus chemo in patients with early stage HER2+ breast cancer.

Research Update for HER2-Positive MBC | 2022-2023 EMBRACE MBC Virtual Forum Series Video

Research Update for HER2-Positive MBC | 2022-2023 EMBRACE MBC Virtual Forum Series

Philip Poorvu, MD; Adrienne Waks, MD; and Christine Agius, NP, discuss advances in research and treatment for patients with HER2-positive metastatic breast cancer.